James R Turk Selected Research

James R Turk Research Topics

Disease

7	Neoplasms (Cancer) 01/2021 - 09/2002
5	Neoplasm Metastasis (Metastasis) 09/2009 - 09/2002
4	Thrombosis (Thrombus) 01/2017 - 01/2013
4	Hypercholesterolemia 10/2014 - 03/2004
3	Inflammation (Inflammations) 01/2017 - 09/2003
3	Vascular Remodeling 05/2008 - 11/2004
2	Stroke (Strokes) 01/2021 - 08/2020
2	Myocardial Infarction 01/2021 - 08/2020
2	Body Weight (Weight, Body) 01/2017 - 02/2002
2	Atherosclerosis 11/2004 - 10/2004
1	Left Ventricular Dysfunction 01/2021
1	Heart Failure 01/2021
1	Osteoporosis 08/2020
1	Thrombophilia 01/2017
1	Disseminated Intravascular Coagulation 01/2017
1	Leukopenia 01/2017
1	Vascular System Injuries 09/2016
1	Iron Deficiencies 01/2014
1	Hemorrhage 01/2013
1	Disease Progression 01/2012
1	Cystitis 08/2008
1	Transitional Cell Carcinoma 08/2008
1	Weight Gain 06/2008
1	Hypoxia (Hypoxemia) 05/2008
1	Uveitis 11/2007
1	Microvascular Rarefaction 08/2007
1	Hemangiosarcoma (Angiosarcoma) 08/2007
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2007
1	Overweight 10/2006
1	Hypoalbuminemia 03/2006
1	Hyponatremia 03/2006
1	Hyperglycemia 03/2006
1	Lymphopenia (Lymphocytopenia) 03/2006
1	Azotemia 03/2006
1	Coronary Disease (Coronary Heart Disease) 09/2004
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2004
1	Carcinoma (Carcinomatosis) 01/2004
1	Adenosarcoma 11/2003
1	Smooth Muscle Tumor 11/2003

Drug/Important Bio-Agent (IBA)

4	Galectin 3 (LGALS3)IBA 09/2009 - 07/2003
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 06/2013
2	Alendronate (Alendronate Sodium)FDA LinkGeneric 01/2021 - 08/2020
2	romosozumabIBA 01/2021 - 08/2020
2	Monoclonal AntibodiesIBA 08/2020 - 06/2013
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 10/2006
2	Pharmaceutical PreparationsIBA 09/2016 - 01/2013
2	CholesterolIBA 10/2015 - 09/2004
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 05/2008
2	CarbohydratesIBA 09/2009 - 01/2004
2	Galectins (Galectin)IBA 09/2009 - 08/2007
2	Hormones (Hormone)IBA 05/2008 - 08/2007
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2005 - 03/2004
2	Matrix Metalloproteinases (MMPs)IBA 11/2004 - 09/2002
2	Thomsen-Friedenreich antigenIBA 01/2004 - 07/2003
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	EndotoxinsIBA 01/2017
1	Dacarbazine (DIC)FDA LinkGeneric 01/2017
1	Hemostatics (Antihemorrhagics)IBA 01/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	Ethanol (Ethyl Alcohol)IBA 10/2015
1	Biological ProductsIBA 10/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2015
1	GlycogenIBA 10/2015
1	oxidized low density lipoproteinIBA 10/2014
1	HematinicsIBA 01/2014
1	Tissue Inhibitor of MetalloproteinasesIBA 01/2014
1	Oncostatin MIBA 01/2014
1	CytokinesIBA 01/2014
1	Antithrombin IIIIBA 01/2014
1	von Willebrand FactorIBA 01/2014
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2014
1	Interleukin-11 (Interleukin 11)IBA 01/2014
1	Stem Cell FactorIBA 01/2014
1	IronIBA 01/2014
1	AntibodiesIBA 06/2013
1	AntioxidantsIBA 01/2012
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2009
1	Leucine (L-Leucine)FDA Link 09/2009
1	SurvivinIBA 08/2008
1	Insulin (Novolin)FDA Link 06/2008
1	Insulin-Like Growth Factor I (IGF-1)IBA 06/2008
1	Blood Glucose (Blood Sugar)IBA 06/2008
1	AntigensIBA 11/2007
1	DNA (Deoxyribonucleic Acid)IBA 11/2007
1	Interleukin-6 (Interleukin 6)IBA 08/2007
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 02/2007
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 03/2006
1	Creatine Kinase (Creatine Phosphokinase)IBA 03/2006
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 10/2005
1	LDL Lipoproteins (beta Lipoproteins)IBA 11/2004
1	Nitric Oxide Synthase (NO Synthase)IBA 03/2004
1	Glycoproteins (Glycoprotein)IBA 01/2004
1	VimentinIBA 11/2003
1	Vancomycin FDA LinkGeneric 11/2003
1	SolutionsIBA 11/2003

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2021 - 08/2007
1	Intraperitoneal Injections 01/2017
1	Therapeutics 09/2009
1	Lasers (Laser) 08/2007
1	Secondary Prevention 10/2004